CURE — DIREXION SHS ETF TR

Ownership history in TAP Consulting, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which TAP Consulting, LLC reported a position in DIREXION SHS ETF TR (CURE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2024 Q3)
Avg. % of fund
0.04%
First filed
2021 Q4
Last filed
2024 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 ADDED 1,791 +66 +3.8% 0.05% $239K $131.20
2024 Q2 ADDED 1,725 +541 +45.7% 0.04% $201K $114.79
2021 Q4 INITIATED 1,184 — — 0.04% $172K $138.10
% of Fund (quarterly)    CURE price (monthly, adj. close)

Other funds also holding CURE

As of 2025 Q4 — sorted by position size

Bullseye Investment Management, LLC 3Y 1.06% GTS SECURITIES LLC 0.09% Frazier Financial Advisors, LLC 0.07% Virtu Financial LLC 3Y 7Y 0.06% Traynor Capital Management, Inc. 3Y 7Y 0.03% Onyx Bridge Wealth Group LLC 3Y 0.03% Tower Research Capital LLC (TRC) 3Y 7Y 0.02% Pinnacle Wealth Planning Services, Inc. 3Y 7Y 0.01% Summit Financial, LLC 3Y 7Y 0.0% SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0%
← Back to TAP Consulting, LLC Holdings